Mechanism of Action 5-Amino-1MQ acts as a potent and selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme highly expressed in adipose tissue, liver, and certain metabolically active cells
The high subgroup heterogeneity primarily reflects considerable diversity within the cognitive impairment group regarding aetiology (e.g., AD, PD, and MCI), disease severity, and comorbidities
It is also admired for having ability to treat malnutrition and assist in maintaining proper metabolic processes
The application of GABA and DSIP-CBBBP treatments increases dopamine levels, suggesting a potential neuroprotective or restorative effect, whereas CBBBP and DSIP treatments do not show a significant impact on dopamine levels, indicating their insufficiency in altering dopamine concentrations in this context